Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
<strong>Background:</strong> Chloroquine (CQ) is the first-line treatment for vivax malaria in Ethiopia, but there is evidence for its declining efficacy. Defining the extent and regional distribution of CQ resistance is critical to ensure optimal treatment guidelines. This study aimed t...
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
BioMed Central
2015
|